STUDY

Avodart pills ranked first for thicker hair

“The impact of monotherapies for male androgenetic alopecia: A network meta-analysis study.” Gupta AK et al. Journal of Cosmetic Dermatology. September 2024

Gupta AK et al. · Journal of Cosmetic Dermatology · September 2024

Network meta-analysis
The finding

This analysis ranked 20 single treatments for male pattern hair loss using 6-month hair density. Oral dutasteride 0.5 mg ranked first, and oral drugs that block DHT (finasteride and dutasteride) ranked above oral minoxidil.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Network meta-analysis. This method lets researchers compare treatments that were never tested head to head, by linking trials through shared comparisons such as placebo.
At a glance

Who was studied and for how long

Evidence
Published trials
Found by a systematic search
Compared
20 treatments + control
Placebo or vehicle
Who
Adult men
Age 18 and older
Measured
6-month change
Total and terminal hair density
What they did

How the study worked

1. SearchThe authors searched the published literature for suitable trials.
2. LinkThey linked treatments to each other through shared comparison groups.
3. RankA statistical model ranked each treatment on hair density change.
What they found

The results

Highest ranking treatment

Oral dutasteride 0.5 mg daily ranked first at six months. Its SUCRA scores were 87% for total hair density and 98% for terminal hair density.

Other treatments

The authors reported that oral 5-alpha reductase inhibitors ranked above oral minoxidil in their analyses. Estimates depend on the dose and which trials were available.

SUCRA summarizes a ranking across the network. It is not the percentage of patients who improved or the size of the effect.
How much to trust it

Strengths and limits

Strengths

  • Covers 20 treatments in one analysis
  • Uses a clear outcome: 6-month hair density
  • Shows that dose matters

Limits

  • Many comparisons are indirect, not head to head
  • Men only
  • Results depend on which trials were included
  • The abstract does not list the trial count or funding
Moderate confidence. A useful big-picture ranking, but built on indirect comparisons.
What it means for you

The takeaway

Dutasteride ranked first

Across published trials, oral dutasteride ranked highest for hair density in men, and oral finasteride and dutasteride ranked above oral minoxidil.

Rankings are not a prescription. Side effects and your health history matter too, so talk with your dermatologist.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

Network meta-analysis

A method that ranks several treatments by linking many trials together.

5-alpha reductase inhibitor

A drug that lowers DHT, the hormone behind pattern hair loss. Finasteride and dutasteride are examples.

Terminal hair

Thick, fully grown hair.

SUCRA

A score from 0 to 100% showing how often a treatment ranks near the top.

Original source

Gupta AK, Bamimore MA, Wang T, Talukder M. The impact of monotherapies for male androgenetic alopecia: A network meta-analysis study.. J Cosmet Dermatol. 2024;23(9):2964-2972.

PMID 38725143